JP2018525703A5 - - Google Patents

Download PDF

Info

Publication number
JP2018525703A5
JP2018525703A5 JP2017561708A JP2017561708A JP2018525703A5 JP 2018525703 A5 JP2018525703 A5 JP 2018525703A5 JP 2017561708 A JP2017561708 A JP 2017561708A JP 2017561708 A JP2017561708 A JP 2017561708A JP 2018525703 A5 JP2018525703 A5 JP 2018525703A5
Authority
JP
Japan
Prior art keywords
biomarker
value
values
determining
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017561708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018525703A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/050388 external-priority patent/WO2016187655A1/en
Publication of JP2018525703A publication Critical patent/JP2018525703A/ja
Publication of JP2018525703A5 publication Critical patent/JP2018525703A5/ja
Pending legal-status Critical Current

Links

JP2017561708A 2015-05-28 2016-05-20 バイオマーカー測定の妥当性確認 Pending JP2018525703A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015901982A AU2015901982A0 (en) 2015-05-28 Validating biomarker measurement
AU2015901982 2015-05-28
PCT/AU2016/050388 WO2016187655A1 (en) 2015-05-28 2016-05-20 Validating biomarker measurement

Publications (2)

Publication Number Publication Date
JP2018525703A JP2018525703A (ja) 2018-09-06
JP2018525703A5 true JP2018525703A5 (enExample) 2019-06-27

Family

ID=57392259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017561708A Pending JP2018525703A (ja) 2015-05-28 2016-05-20 バイオマーカー測定の妥当性確認

Country Status (9)

Country Link
US (2) US10719579B2 (enExample)
EP (1) EP3304093B1 (enExample)
JP (1) JP2018525703A (enExample)
CN (1) CN108323184A (enExample)
AU (1) AU2016267392B2 (enExample)
CA (1) CA2986787A1 (enExample)
DK (1) DK3304093T3 (enExample)
HK (1) HK1249182A1 (enExample)
WO (1) WO2016187655A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016267392B2 (en) * 2015-05-28 2021-12-09 Immunexpress Pty Ltd Validating biomarker measurement
US20180357361A1 (en) * 2017-06-13 2018-12-13 Feliks Frenkel Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
ES2923478T3 (es) 2017-08-04 2022-09-27 Billiontoone Inc Determinación y análisis de resultados de una secuenciación con moléculas asociadas a una diana en una cuantificación asociada con dianas biológicas
WO2019046814A1 (en) 2017-09-01 2019-03-07 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR THE DIAGNOSIS AND MONITORING OF TREATMENT
WO2019183052A1 (en) * 2018-03-19 2019-09-26 Sri International Methods and systems for biomarker analysis
CN109055535A (zh) * 2018-09-14 2018-12-21 北京泱深生物信息技术有限公司 血液中的分子作为诊断脓毒症的标志物
CN109374904A (zh) * 2018-10-29 2019-02-22 浙江医院 一种蛋白质类脓毒症标志物及其在严重脓毒症早期预警的应用及其筛选方法
CN114829882B (zh) * 2019-11-05 2023-02-28 阿比尔技术公司 植物产品中感染的预测
US11049590B1 (en) 2020-02-12 2021-06-29 Peptilogics, Inc. Artificial intelligence engine architecture for generating candidate drugs
WO2021202620A1 (en) * 2020-03-31 2021-10-07 The Board Of Trustees Of The Leland Stanford Junior University Metabolomics approach combined with machine learning to recognize a medical condition
CN113488107B (zh) * 2021-07-07 2022-07-19 广州华银康医疗集团股份有限公司 筛选免疫组库测序生物标志物的方法、设备和存储介质
EP4195212A1 (en) * 2021-12-08 2023-06-14 A3P Biomedical AB (publ) Certainty-based medical conclusion model adaptation
CN114628024A (zh) * 2022-02-24 2022-06-14 重庆市急救医疗中心(重庆市第四人民医院、重庆市急救医学研究所) 一种生物标志物组在制备用于辅助筛查脓毒症的产品中的用途和辅助筛查方法及其系统
WO2025094604A1 (ja) * 2023-10-31 2025-05-08 アークレイ株式会社 検知方法、検知装置、検知システム、検知プログラム、及び記録媒体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148339A1 (en) 2001-05-07 2003-08-07 Hrissi Samartzidou Artificial genes for use as controls in gene expression analysis systems
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US20040180365A1 (en) * 2002-12-13 2004-09-16 Affymetrix, Inc. Methods and computer software products for gene expression data quality analysis
EP1789786A4 (en) * 2004-08-18 2008-02-13 Abbott Molecular Inc DETERMINING DATA QUALITY AND / OR SEGMENTAL ANEUMS USING A COMPUTER SYSTEM
BRPI0609302A2 (pt) * 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US20070255113A1 (en) * 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US20080213768A1 (en) * 2006-08-17 2008-09-04 Zhauhui Cai Identification and use of biomarkers for non-invasive and early detection of liver injury
DE102007010252B4 (de) 2007-03-02 2013-07-04 Sirs-Lab Gmbh Kontrollgene zur Normalisierung von Genexpressionsanalysedaten
CA2604317C (en) * 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
JP4666237B2 (ja) * 2008-07-09 2011-04-06 ソニー株式会社 遺伝子検定方法、遺伝子検定プログラム及び遺伝子検定装置
JP2013509588A (ja) * 2009-10-29 2013-03-14 テシス バイオサイエンス, インコーポレイテッド 2型糖尿病の予防に対して一貫した改善をもたらすタンパク質バイオマーカーおよび脂質代謝物バイオマーカー
US20120035860A1 (en) * 2010-04-29 2012-02-09 Akmaev Viatcheslav R GC Wave Correction for Array-Based Comparative Genomic Hybridization
EP2643483A4 (en) * 2010-11-26 2014-04-30 Immunexpress Pty Ltd DIAGNOSTIC AND / OR SCREENING APPROPRIATIONS AND USES THEREFOR
CA2827894A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
JP6211511B2 (ja) * 2011-04-18 2017-10-11 ディアミール, エルエルシーDiamir, Llc miRNAに基づくユニバーサルスクリーニングテスト(UST)
WO2013152989A2 (en) * 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
EP2836844B1 (en) * 2012-04-13 2017-08-16 Oasis Diagnostics Corporation Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
WO2014201516A2 (en) 2013-06-20 2014-12-24 Immunexpress Pty Ltd Biomarker identification
EP3103046B1 (en) 2014-02-06 2020-03-25 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
AU2016267392B2 (en) * 2015-05-28 2021-12-09 Immunexpress Pty Ltd Validating biomarker measurement

Similar Documents

Publication Publication Date Title
JP2018525703A5 (enExample)
Boyd et al. Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies
Li et al. Comparing the normalization methods for the differential analysis of Illumina high-throughput RNA-Seq data
Hung et al. Analysis of microarray and RNA-seq expression profiling data
Bock Analysing and interpreting DNA methylation data
Larson et al. Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project
US11111538B2 (en) Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing
CN106164295B (zh) 减小基因组覆盖测量中的偏差
Topa et al. Gaussian process test for high-throughput sequencing time series: application to experimental evolution
Varshavsky et al. Accurate age prediction from blood using a small set of DNA methylation sites and a cohort-based machine learning algorithm
WO2019143845A1 (en) Phenotypic age and dna methylation based biomarkers for life expectancy and morbidity
Alkanaq et al. Comparison of mitochondrial DNA variants detection using short-and long-read sequencing
Sauk et al. NIPTmer: rapid k-mer-based software package for detection of fetal aneuploidies
Deleye et al. Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods
WO2014066984A1 (en) Method for identifying a target molecular profile associated with a target cell population
Teder et al. Computational framework for targeted high-coverage sequencing based NIPT
Morganella et al. Finding recurrent copy number alterations preserving within-sample homogeneity
Kim et al. Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson’s disease
Koike et al. Comparative analysis of copy number variation detection methods and database construction
Seo et al. Deconvoluting complex tissues for expression quantitative trait locus-based analyses
CN113728391A (zh) 用于基于上下文压缩免疫肿瘤学生物标志物的基因组数据的方法
WO2010126371A1 (en) Method of pooling samples for performing a biological assay
KR102348688B1 (ko) 냉증 진단용 snp 마커 및 이의 용도
Chong et al. SeqControl: process control for DNA sequencing
Dannemann et al. The effects of probe binding affinity differences on gene expression measurements and how to deal with them